Exploring the Therapeutic Potential of Flavonoids in the Management of Cancer
- PMID: 38591206
- DOI: 10.2174/0113892010297456240327062614
Exploring the Therapeutic Potential of Flavonoids in the Management of Cancer
Abstract
Flavonoids are a class of polyphenolic compounds that can be classified into six distinct categories, namely isoflavonoids, flavanones, flavanols, flavonols, flavones, and anthocyanidins. These compounds are naturally occurring and can be found in a diverse range of plant species. Flavonoids, a class of bioactive compounds, are mostly obtained through the consumption of vegetables, fruits and plant-derived beverages such as wine, cocoa-based products and green tea. Flavonoids have been demonstrated to exhibit a diverse range of anticancer properties. These include the modulation of activities of enzymes involved in scavenging reactive oxygen species, involvement in cell cycle arrest, induction of apoptosis and autophagy, as well as suppression of cancer cell proliferation and invasiveness. Flavonoids exhibit a dual role in maintaining reactive oxygen species balance. They function as antioxidants in regular physiological conditions, while also demonstrating significant pro-oxidant properties in cancer cells. This prooxidant activity induces apoptotic pathways and downregulates pro-inflammatory signalling pathways. The paper explores the biochemical characteristics, bioavailability, anticancer efficacy, and modes of action of flavonoids.
Keywords: Cancer; cell proliferation; flavonoids; gut microbiota.; oxidant; reactive oxygen species.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Flavonoids as Anticancer Agents.Nutrients. 2020 Feb 12;12(2):457. doi: 10.3390/nu12020457. Nutrients. 2020. PMID: 32059369 Free PMC article. Review.
-
Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets.Clin Sci (Lond). 2020 Jun 26;134(12):1403-1432. doi: 10.1042/CS20200356. Clin Sci (Lond). 2020. PMID: 32556180 Review.
-
Harnessing Plant Flavonoids to Fight Pancreatic Cancer.Curr Nutr Rep. 2024 Sep;13(3):566-581. doi: 10.1007/s13668-024-00545-9. Epub 2024 May 3. Curr Nutr Rep. 2024. PMID: 38700837 Review.
-
Dietary flavonoids: bioavailability, metabolic effects, and safety.Annu Rev Nutr. 2002;22:19-34. doi: 10.1146/annurev.nutr.22.111401.144957. Epub 2002 Jan 4. Annu Rev Nutr. 2002. PMID: 12055336 Review.
-
Flavonoids: prospective drug candidates.Mini Rev Med Chem. 2008 Nov;8(13):1429-40. doi: 10.2174/138955708786369564. Mini Rev Med Chem. 2008. PMID: 18991758 Review.
Cited by
-
Network pharmacology and UHPLC-HRMS reveal the mechanism of QSFZYL and BMSCs overexpressing IFN-γ against lung adenocarcinoma.Front Immunol. 2025 Jun 26;16:1593121. doi: 10.3389/fimmu.2025.1593121. eCollection 2025. Front Immunol. 2025. PMID: 40642092 Free PMC article.
-
Evaluation of In Vitro Biological Activity of Flavanone/Chromanone Derivatives: Molecular Analysis of Anticancer Mechanisms in Colorectal Cancer.Int J Mol Sci. 2024 Dec 3;25(23):12985. doi: 10.3390/ijms252312985. Int J Mol Sci. 2024. PMID: 39684693 Free PMC article.
-
Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma Models.EJHaem. 2025 Jun 19;6(3):e70081. doi: 10.1002/jha2.70081. eCollection 2025 Jun. EJHaem. 2025. PMID: 40538494 Free PMC article.
References
-
- Nabavi S.M.; Šamec D.; Tomczyk M.; Milella L.; Russo D.; Habtemariam S.; Suntar I.; Rastrelli L.; Daglia M.; Xiao J.; Giampieri F.; Battino M.; Sobarzo-Sanchez E.; Nabavi S.F.; Yousefi B.; Jeandet P.; Xu S.; Shirooie S.; Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnol Adv 2020,38,107316 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical